← 產業報告目錄

Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Filling, Spray Drying, Mixing & Blending, Milling, Tablet Compression, Inspection, Granulation, Sterilization), End Product (Solid, Liquid), Technology - Global Forecast to 2032

出版商 MarketsandMarkets產業別 Electronics & Semiconductor出版日期 2026-02-26頁數 322報告編號 SE8645

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global pharmaceutical manufacturing equipment market size is projected to be USD 21.24 billion in 2026 and USD 30.39 billion by 2032, registering a CAGR of 6.2% during the forecast period. The market is progressing steadily due to the rising demand for efficient and compliant drug production systems. Pharmaceutical companies are expanding production capacity to meet growing medicine demand. Process accuracy and product quality remain key priorities. Regulatory compliance requirements drive the modernization of production lines. Increasing demand for generic drugs and biologics supports scalable manufacturing solutions. Strict quality standards require validated and reliable equipment. Investment in pharmaceutical infrastructure continues to rise. These factors support the adoption of advanced manufacturing equipment across global pharmaceutical facilities. “Packaging machines segment is anticipated to grow at the fastest CAGR from 2026 to 2032” Packing machines are expected to record the highest CAGR during the forecast period due to the growing emphasis on safe and compliant pharmaceutical packaging. Pharmaceutical companies are prioritizing product protection and shelf life extension. Strict regulatory requirements are increasing investment in advanced packaging systems. The growing production of tablets and capsules is raising packaging volumes. Injectable drugs also require secure handling. Demand for tamper-proof packaging is increasing. Additionally, the increasing adoption of automation and serialization technologies to ensure traceability and reduce counterfeiting risks is further accelerating the demand for advanced packaging machines across pharmaceutical manufacturing facilities. “Liquid segment is expected to dominate the pharmaceutical manufacturing equipment market during the forecast period” The liquid segment is expected to account for the largest market share during the forecast period due to the mounting demand for injectables and biologics. Vaccines and oral liquid medicines are also driving production growth. The increasing prevalence of chronic diseases supports the higher output of sterile formulations. Expansion of immunization programs strengthens demand across regions. Pharmaceutical companies are investing in advanced filling and sealing systems. Growth in contract manufacturing supports capacity expansion. Patient preference for easy administration is increasing the adoption of liquid forms. This shift supports higher capital investment in liquid manufacturing infrastructure globally. “China held the largest share of the Asia Pacific pharmaceutical manufacturing equipment market in 2025” China accounted for the largest share of the pharmaceutical manufacturing equipment market during the forecast period due to its large-scale production capacity. The country maintains a strong position in active pharmaceutical ingredient (API) and generic drug manufacturing. A wide base of facilities ranges from small domestic producers to export-focused companies. Many plants operate advanced automated production lines. Investment in biologics and vaccines is increasing equipment demand. Sterile manufacturing expansion supports process system upgrades in the country. Contract manufacturing growth drives additional capacity additions, while facility modernization to meet international regulatory standards strengthens demand. These compliance requirements encourage the adoption of validated systems. These factors position it as the leading market for pharmaceutical manufacturing equipment. • By Company Type: Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25% • By Designation: Directors – 40%, C-level Executives – 45%, and Others – 15% • By Region: North America – 26%, Europe – 28%, Asia Pacific – 41%, and RoW – 5% Prominent players profiled in this report include GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), Thermo Fisher Scientific Inc (US), Körber AG (Germany), Coperion GmbH (Germany), Romaco Group (Germany), Marchesini Group S.p.A (Italy), and Bausch+Ströbel SE + Co. KG (Germany). Research Coverage The report defines, describes, and forecasts the pharmaceutical manufacturing equipment market based on equipment type (packaging machines, filling machines, spray drying equipment, mixing & blending machines, milling equipment, extrusion equipment, tablet compression presses, inspection equipment, granulation equipment, and sterilization equipment), end-product type (solid and liquid), and technology (semi-automatic and automatic). It also analyzes the market across key regions, including North America, Europe, Asia Pacific, and RoW. The report provides detailed insights into the major drivers, restraints, opportunities, and challenges influencing market growth. In addition, it evaluates competitive developments, such as product launches, expansions, partnerships, acquisitions, and strategic initiatives undertaken by leading companies to strengthen their market position. Reasons to Buy This Report The report will help market leaders/new entrants with information on the closest approximations of the revenue for the overall pharmaceutical manufacturing equipment market and its subsegments. The report will help stakeholders understand the competitive landscape and gain more insight to position their business better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market’s pulse and provides information on key drivers, restraints, opportunities, and challenges. The report will provide insights into the following points: • Analysis of Key Drivers (Increasing commercialization of biologics and complex formulations, Growing preference for personalized medicines and targeted therapies, Rapid advances in automation, digital monitoring, and Industry 4.0 technologies, Escalating generic drug production), restraints (High capital expenditure requirements, Issues related to integration with existing systems, Implementation of stringent regulatory compliance standards), opportunities (Expansion of contract development and manufacturing organizations, Mounting demand for sterile and aseptic injectable drugs, Rising integration of advanced inspection and serialization technologies), and challenges (Requirement for frequent technological upgrades, Complex validation and revalidation cycles, Technical and operational challenges related to small-batch production) of the pharmaceutical manufacturing equipment market. • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product launches in the pharmaceutical manufacturing equipment market • Market Development: Comprehensive information about lucrative markets (the report analyzes the pharmaceutical manufacturing equipment market across various regions) • Market Diversification: Exhaustive information about new product launches, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market • Competitive Assessment: In-depth assessment of market share, growth strategies, and offering of leading players, including GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc (US) in the pharmaceutical manufacturing equipment market
目錄 Table of Contents
1 INTRODUCTION 30 1.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.3 STUDY SCOPE 31 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 31 1.3.2 YEARS CONSIDERED 32 1.3.3 INCLUSIONS AND EXCLUSIONS 32 1.4 CURRENCY CONSIDERED 33 1.5 UNIT CONSIDERED 33 1.6 LIMITATIONS 34 1.7 STAKEHOLDERS 34 1.8 SUMMARY OF CHANGES 34 2 EXECUTIVE SUMMARY 35 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 35 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 36 2.3 DISRUPTIVE TRENDS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 37 2.4 HIGH-GROWTH SEGMENTS 38 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 39 3 PREMIUM INSIGHTS 40 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 40 3.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 41 3.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE 41 3.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY 42 3.5 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY EQUIPMENT TYPE AND COUNTRY 42 3.6 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY GEOGRAPHY 43 4 MARKET OVERVIEW 44 4.1 INTRODUCTION 44 4.2 MARKET DYNAMICS 44 4.2.1 DRIVERS 45 4.2.1.1 Increasing commercialization of biologics and complex formulations 45 4.2.1.2 Growing preference for personalized medicines and targeted therapies 45 4.2.1.3 Rapid advances in automation, digital monitoring, and Industry 4.0 technologies 46 4.2.1.4 Escalating generic drug production 46 4.2.2 RESTRAINTS 47 4.2.2.1 High capital expenditure requirements 47 4.2.2.2 Issues related to integration with existing systems 48 4.2.2.3 Implementation of stringent regulatory compliance standards 48 4.2.3 OPPORTUNITIES 49 4.2.3.1 Expansion of contract development and manufacturing organizations 49 4.2.3.2 Mounting demand for sterile and aseptic injectable drugs 50 4.2.3.3 Rising deployment of advanced inspection and serialization technologies 50 4.2.4 CHALLENGES 51 4.2.4.1 Requirement for frequent technological upgrades 51 4.2.4.2 Complex validation and revalidation cycles 52 4.2.4.3 Technical and operational challenges related to small-batch production 52 4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53 4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 55 5 INDUSTRY TRENDS 57 5.1 PORTER’S FIVE FORCES ANALYSIS 57 5.1.1 BARGAINING POWER OF SUPPLIERS 58 5.1.2 BARGAINING POWER OF BUYERS 59 5.1.3 THREAT OF NEW ENTRANTS 59 5.1.4 THREAT OF SUBSTITUTES 59 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 59 5.2 MACROECONOMIC OUTLOOK 60 5.2.1 INTRODUCTION 60 5.2.2 GDP TRENDS AND FORECAST 60 5.2.3 TRENDS IN GLOBAL BIOPHARMACEUTICAL & VACCINE MANUFACTURING INDUSTRY 62 5.2.4 TRENDS IN GLOBAL GENERIC DRUG & ORAL SOLID DOSAGE MANUFACTURING INDUSTRY 62 5.3 VALUE CHAIN ANALYSIS 63 5.4 ECOSYSTEM ANALYSIS 66 5.5 PRICING ANALYSIS 68 5.5.1 PRICING RANGE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2025 68 5.5.2 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, 2022–2025 69 5.5.3 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, BY REGION, 2022–2025 70 5.6 INVESTMENT AND FUNDING SCENARIO 71 5.7 TRADE ANALYSIS 72 5.7.1 IMPORT SCENARIO (HS CODE 8479) 72 5.7.2 EXPORT SCENARIO (HS CODE 8479) 73   5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74 5.9 KEY CONFERENCES AND EVENTS, 2026 75 5.10 CASE STUDY ANALYSIS 75 5.10.1 INOXPA STRENGTHENS AVVA PHARMACEUTICALS’ MANUFACTURING CAPABILITIES THROUGH MODULAR PHARMACEUTICAL PROCESSING SYSTEM 75 5.10.2 GEA GROUP INSTALLS PSD-3 PHARMACEUTICAL SPRAY DRYER AT CHUGAI PHARMACEUTICAL’S FJ3 FACILITY TO PROCESS PHARMACEUTICAL COMPOUNDS 76 5.10.3 ZAMBON COMPANY AND IMA ACTIVE COLLABORATE ON PROCESS OPTIMIZATION PROJECT TO ENHANCE BATCH CONSISTENCY AND QUALITY 77 5.10.4 ACG HELPS INDIAN PHARMACEUTICAL COMPANY RETROFIT B MAX MACHINE WITH NITROGEN-ENHANCED PURGING SYSTEM TO IMPROVE STABILITY AND SHELF LIFE 78 5.10.5 SYNTEGON PROVIDES AIM 5022S PLATFORM TO JIANGSU JINDIKE PHARMACEUTICAL TO ENHANCE INSPECTION EFFICIENCY AND ACCURACY 79 5.11 IMPACT OF 2025 US TARIFF – PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 80 5.11.1 INTRODUCTION 80 5.11.2 KEY TARIFF RATES 81 5.11.3 PRICE IMPACT ANALYSIS 81 5.11.4 IMPACT ON COUNTRIES/REGIONS 82 5.11.4.1 US 82 5.11.4.2 Europe 83 5.11.4.3 Asia Pacific 84 5.11.5 IMPACT ON EQUIPMENT TYPES 85 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS, PATENTS, AND INNOVATIONS 87 6.1 KEY TECHNOLOGIES 87 6.1.1 CONTINUOUS MANUFACTURING 87 6.1.2 DIGITAL TWIN 87 6.1.3 STERILE AND ASEPTIC PROCESSING 87 6.1.4 SOLID DOSAGE MANUFACTURING 88 6.1.5 AUTOMATION AND ROBOTICS 88 6.1.6 INTERNET OF THINGS (IOT) AND SMART SENSORS 88 6.2 ADJACENT TECHNOLOGIES 89 6.2.1 COMPUTER-AIDED DESIGN (CAD) AND COMPUTER-AIDED MANUFACTURING (CAM) 89 6.2.2 ADVANCED CNC MACHINING AND PRECISION MANUFACTURING 89 6.3 COMPLEMENTARY TECHNOLOGIES 90 6.3.1 3D PRINTING 90 6.3.2 INDUSTRIAL AUTOMATION SYSTEMS 90 6.4 TECHNOLOGY ROADMAP 90 6.5 PATENT ANALYSIS 93 6.6 IMPACT OF AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 95 6.6.1 TOP USE CASES AND MARKET POTENTIAL 96 6.6.2 BEST PRACTICES FOLLOWED BY OEMS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 96 6.6.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 97 6.6.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS 98 6.6.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED PHARMACEUTICAL MANUFACTURING EQUIPMENT 98 7 REGULATORY LANDSCAPE 99 7.1 REGIONAL REGULATIONS AND COMPLIANCE 99 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99 7.1.2 INDUSTRY STANDARDS 101 7.1.3 REGULATIONS 102 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 104 8.1 DECISION-MAKING PROCESS 104 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND EVALUATION CRITERIA 106 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 106 8.2.2 BUYING CRITERIA 107 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 107 8.4 UNMET NEEDS OF EQUIPMENT TYPES 109 9 END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT 111 9.1 INTRODUCTION 111 9.2 PHARMACEUTICAL MANUFACTURING COMPANIES 111 9.3 CONTRACT MANUFACTURING ORGANIZATIONS 112 10 MANUFACTURING PROCESSES OF PHARMACEUTICAL EQUIPMENT 113 10.1 INTRODUCTION 113 10.2 FORMULATION PROCESS 113 10.3 TABLETING & ENCAPSULATION PROCESS 114 10.4 ASEPTIC PROCESS 114 10.5 PACKAGING PROCESS 115 10.6 QUALITY CONTROL PROCESS 115 11 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 116 11.1 INTRODUCTION 117 11.2 PACKAGING MACHINES 120 11.2.1 INCREASING PRODUCT AND STOCK KEEPING UNIT PROLIFERATION TO BOOST SEGMENTAL GROWTH 120 11.3 FILLING MACHINES 125 11.3.1 RISING STERILE AND ASEPTIC MANUFACTURING TO CONTRIBUTE TO SEGMENTAL GROWTH 125 11.4 SPRAY DRYING EQUIPMENT 130 11.4.1 ESCALATING NUMBER OF POORLY SOLUBLE DRUG MOLECULES TO FOSTER SEGMENTAL GROWTH 130 11.5 MIXING & BLENDING MACHINES 135 11.5.1 MOUNTING CONSUMPTION OF SOLID ORAL DOSAGE FORMS TO BOLSTER SEGMENTAL GROWTH 135 11.6 MILLING EQUIPMENT 139 11.6.1 RISING NEED FOR TIGHT PARTICLE SIZE CONTROL TO ACCELERATE SEGMENTAL GROWTH 139 11.7 EXTRUSION EQUIPMENT 144 11.7.1 GROWING EMPHASIS ON IMPROVING BIOAVAILABILITY OF POORLY SOLUBLE DRUGS TO SPUR DEMAND 144 11.8 TABLET COMPRESSION PRESSES 148 11.8.1 LARGE-SCALE PRODUCTION OF TABLETS AND HIGH-VOLUME PRODUCTION REQUIREMENTS TO FUEL SEGMENTAL GROWTH 148 11.9 INSPECTION EQUIPMENT 153 11.9.1 HEIGHTENED FOCUS ON QUALITY ASSURANCE AND RISK REDUCTION TO EXPEDITE SEGMENTAL GROWTH 153 11.10 GRANULATION EQUIPMENT 159 11.10.1 REQUIREMENT FOR CONSISTENT AND REPRODUCIBLE MANUFACTURING PROCESSES TO BOOST SEGMENTAL GROWTH 159 11.11 STERILIZATION EQUIPMENT 163 11.11.1 INCREASING PRODUCTION OF STERILE DRUGS AND REGULATORY SCRUTINY TO FOSTER SEGMENTAL GROWTH 163 12 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE 168 12.1 INTRODUCTION 169 12.2 SOLID 170 12.2.1 STABILITY, EASE OF STORAGE AND TRANSPORT, AND LOW MANUFACTURING COSTS TO AUGMENT SEGMENTAL GROWTH 170 12.3 LIQUID 171 12.3.1 HIGH PREFERENCE FOR BIOLOGICS, VACCINES, AND INJECTABLE THERAPIES TO EXPEDITE SEGMENTAL GROWTH 171 13 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY 172 13.1 INTRODUCTION 173 13.2 SEMI-AUTOMATIC 174 13.2.1 MOUNTING DEMAND FOR SMALL-SCALE AND FLEXIBLE PHARMACEUTICAL MANUFACTURING TO FUEL SEGMENTAL GROWTH 174   13.3 AUTOMATIC 175 13.3.1 RISING NEED FOR HIGH PRODUCTIVITY AND STRINGENT REGULATORY REQUIREMENTS TO AUGMENT SEGMENTAL GROWTH 175 14 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION 176 14.1 INTRODUCTION 177 14.2 NORTH AMERICA 178 14.2.1 US 181 14.2.1.1 Increasing investment in compliance-ready equipment to strengthen healthcare production capabilities to drive market 181 14.2.2 CANADA 183 14.2.2.1 Mounting adoption of automation and regulatory frameworks to foster market growth 183 14.2.3 MEXICO 185 14.2.3.1 Rising domestic track-and-trace requirements and export compliance to support market growth 185 14.3 EUROPE 187 14.3.1 UK 190 14.3.1.1 Government support for life sciences sector and strong regulatory standards to boost market growth 190 14.3.2 GERMANY 192 14.3.2.1 Strong engineering capabilities, advanced automation, and early adoption of digital manufacturing practices to drive market 192 14.3.3 FRANCE 193 14.3.3.1 High investment in validated manufacturing, filling, inspection, and packaging equipment to fuel market growth 193 14.3.4 ITALY 195 14.3.4.1 Growing focus on sterile and high-value manufacturing to contribute to market growth 195 14.3.5 REST OF EUROPE 196 14.4 ASIA PACIFIC 198 14.4.1 CHINA 201 14.4.1.1 Rising emphasis on innovative drug development and automated manufacturing technologies to expedite market growth 201 14.4.2 JAPAN 203 14.4.2.1 Strong focus on manufacturing process control, accuracy, and reliability to accelerate market growth 203 14.4.3 INDIA 205 14.4.3.1 Large-scale generic drug manufacturing base to drive market 205 14.4.4 SOUTH KOREA 206 14.4.4.1 Advanced technological capabilities and strong regulatory framework to foster market growth 206 14.4.5 REST OF ASIA PACIFIC 208   14.5 ROW 210 14.5.1 MIDDLE EAST & AFRICA 212 14.5.1.1 GCC 215 14.5.1.1.1 Rising adoption of healthcare localization and economic diversification strategies to bolster market growth 215 14.5.1.2 South Africa 215 14.5.1.2.1 Increasing vaccine and biologics manufacturing capabilities to augment market growth 215 14.5.1.3 Rest of Middle East & Africa 216 14.5.2 SOUTH AMERICA 216 14.5.2.1 Brazil 218 14.5.2.1.1 Strong focus on compliance with track-and-trace regulations to contribute to market growth 218 14.5.2.2 Argentina 219 14.5.2.2.1 Mounting demand for tablet compression, capsule filling, granulation, and coating equipment to support market growth 219 14.5.2.3 Rest of South America 219 15 COMPETITIVE LANDSCAPE 221 15.1 OVERVIEW 221 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2026 221 15.3 REVENUE ANALYSIS, 2021–2025 224 15.4 MARKET SHARE ANALYSIS, 2O25 224 15.5 COMPANY VALUATION AND FINANCIAL METRICS 227 15.6 BRAND COMPARISON 228 15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 228 15.7.1 STARS 228 15.7.2 EMERGING LEADERS 228 15.7.3 PERVASIVE PLAYERS 229 15.7.4 PARTICIPANTS 229 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 230 15.7.5.1 Company footprint 230 15.7.5.2 Region footprint 231 15.7.5.3 Equipment type footprint 232 15.7.5.4 End-product type footprint 233 15.7.5.5 Technology footprint 234 15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 234 15.8.1 PROGRESSIVE COMPANIES 234 15.8.2 RESPONSIVE COMPANIES 234 15.8.3 DYNAMIC COMPANIES 235 15.8.4 STARTING BLOCKS 235 15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 236 15.8.5.1 Detailed list of key startups/SMEs 236 15.8.5.2 Competitive benchmarking of key startups/SMEs 237 15.9 COMPETITIVE SCENARIO 240 15.9.1 PRODUCT LAUNCHES 240 15.9.2 DEALS 243 15.9.3 EXPANSIONS 249 16 COMPANY PROFILES 251 16.1 KEY PLAYERS 251 16.1.1 GEA GROUP AKTIENGESELLSCHAFT 251 16.1.1.1 Business overview 251 16.1.1.2 Products/Solutions/Services offered 252 16.1.1.3 Recent developments 253 16.1.1.3.1 Product launches 253 16.1.1.3.2 Deals 254 16.1.1.4 MnM view 254 16.1.1.4.1 Key strengths/Right to win 254 16.1.1.4.2 Strategic choices 254 16.1.1.4.3 Weaknesses/Competitive threats 254 16.1.2 KÖRBER AG 255 16.1.2.1 Business overview 255 16.1.2.2 Products/Solutions/Services offered 255 16.1.2.3 Recent developments 256 16.1.2.3.1 Deals 256 16.1.2.3.2 Expansions 258 16.1.2.4 MnM view 258 16.1.2.4.1 Key strengths/Right to win 258 16.1.2.4.2 Strategic choices 258 16.1.2.4.3 Weaknesses/Competitive threats 259 16.1.3 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA 260 16.1.3.1 Business overview 260 16.1.3.2 Products/Solutions/Services offered 261 16.1.3.3 Recent developments 261 16.1.3.3.1 Product launches 261 16.1.3.3.2 Deals 261 16.1.3.4 MnM view 262 16.1.3.4.1 Key strengths/Right to win 262 16.1.3.4.2 Strategic choices 262 16.1.3.4.3 Weaknesses/Competitive threats 263 16.1.4 SYNTEGON TECHNOLOGY GMBH 264 16.1.4.1 Business overview 264 16.1.4.2 Products/Solutions/Services offered 264 16.1.4.3 Recent developments 265 16.1.4.3.1 Product launches 265 16.1.4.3.2 Deals 266 16.1.4.3.3 Expansions 267 16.1.4.4 MnM view 267 16.1.4.4.1 Key strengths/Right to win 267 16.1.4.4.2 Strategic choices 267 16.1.4.4.3 Weaknesses/Competitive threats 267 16.1.5 ACG 268 16.1.5.1 Business overview 268 16.1.5.2 Products/Solutions/Services offered 268 16.1.5.3 Recent developments 269 16.1.5.3.1 Deals 269 16.1.5.3.2 Expansions 269 16.1.5.4 MnM view 269 16.1.5.4.1 Key strengths/Right to win 269 16.1.5.4.2 Strategic choices 270 16.1.5.4.3 Weaknesses/Competitive threats 270 16.1.6 THERMO FISHER SCIENTIFIC INC. 271 16.1.6.1 Business overview 271 16.1.6.2 Products/Solutions/Services offered 272 16.1.6.3 Recent developments 273 16.1.6.3.1 Deals 273 16.1.6.3.2 Expansions 274 16.1.7 ROMACO GROUP 275 16.1.7.1 Business overview 275 16.1.7.2 Products/Solutions/Services offered 275 16.1.7.3 Recent developments 276 16.1.7.3.1 Product launches 276 16.1.7.3.2 Deals 277 16.1.8 MARCHESINI GROUP S.P.A. 278 16.1.8.1 Business overview 278 16.1.8.2 Products/Solutions/Services offered 278 16.1.8.3 Recent developments 279 16.1.8.3.1 Product launches 279 16.1.8.3.2 Deals 279 16.1.9 MG2 S.R.L. 281 16.1.9.1 Business overview 281 16.1.9.2 Products/Solutions/Services offered 281 16.1.9.3 Recent developments 282 16.1.9.3.1 Product launches 282   16.1.10 GLATT GMBH 283 16.1.10.1 Business overview 283 16.1.10.2 Products/Solutions/Services offered 283 16.2 OTHER PLAYERS 284 16.2.1 BAUSCH+STRÖBEL SE + CO. KG 284 16.2.2 COPERION GMBH 285 16.2.3 ELIZABETH COMPANIES 286 16.2.4 FETTE COMPACTING 287 16.2.5 FREUND 288 16.2.6 KORSCH AG 289 16.2.7 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH 290 16.2.8 LFA MACHINES 291 16.2.9 CVC TECHNOLOGIES, INC. 292 16.2.10 OHARA TECHNOLOGIES 293 16.2.11 PRISM PHARMA MACHINERY 294 16.2.12 SAINTYCO 295 16.2.13 SILVERSON 296 16.2.14 YENCHEN MACHINERY CO., LTD. 297 16.2.15 QUALICAPS 298 16.2.16 COESIA S.P.A. 299 16.2.17 UHLMANN 300 16.2.18 AST, LLC 301 17 RESEARCH METHODOLOGY 302 17.1 RESEARCH DATA 302 17.1.1 SECONDARY AND PRIMARY RESEARCH 303 17.1.2 SECONDARY DATA 304 17.1.2.1 List of key secondary sources 304 17.1.2.2 Key data from secondary sources 304 17.1.3 PRIMARY DATA 305 17.1.3.1 List of primary interview participants 305 17.1.3.2 Key data from primary sources 306 17.1.3.3 Key industry insights 306 17.1.3.4 Breakdown of primaries 307 17.2 MARKET SIZE ESTIMATION 307 17.2.1 BOTTOM-UP APPROACH 307 17.2.2 TOP-DOWN APPROACH 308 17.2.3 MARKET SIZE CALCULATION FOR BASE YEAR 309 17.3 MARKET FORECAST APPROACH 309 17.3.1 SUPPLY SIDE 309 17.3.2 DEMAND SIDE 309   17.4 FACTOR ANALYSIS 310 17.5 DATA TRIANGULATION 311 17.6 RESEARCH ASSUMPTIONS 312 17.7 RESEARCH LIMITATIONS 312 17.8 RISK ANALYSIS 313 18 APPENDIX 314 18.1 INSIGHTS FROM INDUSTRY EXPERTS 314 18.2 DISCUSSION GUIDE 315 18.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 318 18.4 CUSTOMIZATION OPTIONS 320 18.5 RELATED REPORTS 320 18.6 AUTHOR DETAILS 321
圖表清單 List of Tables & Figures
TABLE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS 32 TABLE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: SUMMARY OF CHANGES 34 TABLE 3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 54 TABLE 4 STRATEGIC FOCUS OF MAJOR COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 55 TABLE 5 IMPACT OF PORTER’S FIVE FORCES 57 TABLE 6 GDP GROWTH RATES, BY COUNTRY, 2021–2030 (%) 60 TABLE 7 ROLE OF COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM 67 TABLE 8 PRICING RANGE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT PROVIDED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2025 (USD) 68 TABLE 9 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, 2022–2025 (USD) 69 TABLE 10 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, BY REGION, 2022–2025 (USD) 70 TABLE 11 IMPORT DATA FOR HS CODE 8479-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 72 TABLE 12 EXPORT DATA FOR HS CODE 8479-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 73 TABLE 13 LIST OF KEY CONFERENCES AND EVENTS, 2026 75 TABLE 14 INOXPA IMPLEMENTS MODULAR PHARMACEUTICAL PROCESSING SYSTEM TO STRENGTHEN AVVA PHARMACEUTICALS’ MANUFACTURING CAPABILITIES 75 TABLE 15 GEA SUPPLIES PSD-3 PHARMACEUTICAL SPRAY DRYER TO HELP CHUGAI PHARMACEUTICAL PROCESS PHARMACEUTICAL COMPOUNDS 76 TABLE 16 ZAMBON COMPANY UNITES WITH IMA ACTIVE ON PROCESS OPTIMIZATION PROJECT TO SUPPORT PRODUCTION CAPACITY AND MAINTAIN OPERATIONAL EFFICIENCY 77 TABLE 17 ACG DEVELOPS RETROFIT SOLUTION TO INCREASE STABILITY AND SHELF LIFE OF INDIAN PHARMACEUTICAL COMPANY 78 TABLE 18 SYNTEGON’S AIM 5022S PLATFORM HELPS JIANGSU JINDIKE PHARMACEUTICAL ENHANCE INSPECTION EFFICIENCY AND ACCURACY OF PRE-FILLED SYRINGES 79 TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 81 TABLE 20 TECHNOLOGY ROADMAP IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 91 TABLE 21 LIST OF KEY PATENTS, 2023–2025 94 TABLE 22 TOP USE CASES AND MARKET POTENTIAL 96 TABLE 23 BEST PRACTICES FOLLOWED BY COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 96 TABLE 24 CASE STUDIES ON AI IMPLEMENTATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 97 TABLE 25 INTERCONNECTED ECOSYSTEM AND IMPACT ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET PLAYERS 98 TABLE 26 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99 TABLE 27 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 28 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 29 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 30 PHARMACEUTICAL MANUFACTURING EQUIPMENT INDUSTRY STANDARDS 101 TABLE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-PRODUCT TYPE (%) 106 TABLE 32 KEY BUYING CRITERIA FOR END-PRODUCT TYPES 107 TABLE 33 UNMET NEEDS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 109 TABLE 34 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 118 TABLE 35 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 118 TABLE 36 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (THOUSAND UNITS) 119 TABLE 37 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (THOUSAND UNITS) 119 TABLE 38 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 121 TABLE 39 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 121 TABLE 40 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 121 TABLE 41 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 122 TABLE 42 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 122 TABLE 43 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 122 TABLE 44 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 123 TABLE 45 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 123 TABLE 46 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 123 TABLE 47 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 124 TABLE 48 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 124 TABLE 49 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 124 TABLE 50 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 126 TABLE 51 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 126 TABLE 52 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 126 TABLE 53 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 127 TABLE 54 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 127 TABLE 55 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 127 TABLE 56 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 128 TABLE 57 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 128 TABLE 58 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 128 TABLE 59 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 129 TABLE 60 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 129 TABLE 61 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 129 TABLE 62 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 131 TABLE 63 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 131 TABLE 64 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 131 TABLE 65 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 132 TABLE 66 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 132 TABLE 67 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 132 TABLE 68 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 133 TABLE 69 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 133 TABLE 70 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 133 TABLE 71 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 134 TABLE 72 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 134 TABLE 73 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 134 TABLE 74 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 135 TABLE 75 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 135 TABLE 76 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 136 TABLE 77 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 136 TABLE 78 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 136 TABLE 79 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 137 TABLE 80 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 137 TABLE 81 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 138 TABLE 82 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 138 TABLE 83 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 138 TABLE 84 MIXING & BLENDING: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 138 TABLE 85 MIXING & BLENDING: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 139 TABLE 86 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 139 TABLE 87 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 140 TABLE 88 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 140 TABLE 89 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 140 TABLE 90 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 141 TABLE 91 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 141 TABLE 92 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 142 TABLE 93 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 142 TABLE 94 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 142 TABLE 95 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 143 TABLE 96 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 143 TABLE 97 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 143 TABLE 98 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 144 TABLE 99 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 144 TABLE 100 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 145 TABLE 101 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 145 TABLE 102 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 145 TABLE 103 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 146 TABLE 104 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 146 TABLE 105 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 147 TABLE 106 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 147 TABLE 107 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 147 TABLE 108 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 148 TABLE 109 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 148 TABLE 110 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 149 TABLE 111 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 149 TABLE 112 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 150 TABLE 113 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 150 TABLE 114 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 150 TABLE 115 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 151 TABLE 116 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 151 TABLE 117 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 152 TABLE 118 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 152 TABLE 119 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 152 TABLE 120 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 153 TABLE 121 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 153 TABLE 122 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 154 TABLE 123 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 155 TABLE 124 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 155 TABLE 125 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 155 TABLE 126 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 156 TABLE 127 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 156 TABLE 128 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 157 TABLE 129 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 157 TABLE 130 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 157 TABLE 131 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 158 TABLE 132 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 158 TABLE 133 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 158 TABLE 134 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 159 TABLE 135 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 159 TABLE 136 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 160 TABLE 137 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 160 TABLE 138 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 160 TABLE 139 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 161 TABLE 140 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 161 TABLE 141 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 162 TABLE 142 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 162 TABLE 143 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 162 TABLE 144 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 163 TABLE 145 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 163 TABLE 146 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 164 TABLE 147 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 164 TABLE 148 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION) 164 TABLE 149 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION) 165 TABLE 150 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION) 165 TABLE 151 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION) 165 TABLE 152 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION) 166 TABLE 153 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION) 166 TABLE 154 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION) 166 TABLE 155 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION) 167 TABLE 156 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 167 TABLE 157 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION) 167 TABLE 158 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION) 170 TABLE 159 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032, (USD MILLION) 170 TABLE 160 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY, 2021–2025 (USD MILLION) 174 TABLE 161 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY, 2026–2032, (USD MILLION) 174 TABLE 162 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 177 TABLE 163 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 178 TABLE 164 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION) 179 TABLE 165 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 180 TABLE 166 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 180 TABLE 167 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 181 TABLE 168 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 182 TABLE 169 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 183 TABLE 170 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 184 TABLE 171 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 185 TABLE 172 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 186 TABLE 173 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 186 TABLE 174 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION) 188 TABLE 175 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 189 TABLE 176 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 189 TABLE 177 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 190 TABLE 178 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 191 TABLE 179 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 191 TABLE 180 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 192 TABLE 181 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 193 TABLE 182 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 194 TABLE 183 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 194 TABLE 184 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 195 TABLE 185 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 196 TABLE 186 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 197 TABLE 187 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 197 TABLE 188 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION) 199 TABLE 189 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 200 TABLE 190 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 200 TABLE 191 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 201 TABLE 192 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 202 TABLE 193 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 203 TABLE 194 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 204 TABLE 195 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 204 TABLE 196 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 205 TABLE 197 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 206 TABLE 198 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 207 TABLE 199 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 208 TABLE 200 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 209 TABLE 201 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 209 TABLE 202 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION) 210 TABLE 203 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION) 211 TABLE 204 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 211 TABLE 205 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 212 TABLE 206 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION) 213 TABLE 207 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 213 TABLE 208 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 214 TABLE 209 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 214 TABLE 210 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION) 217 TABLE 211 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION) 217 TABLE 212 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION) 218 TABLE 213 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION) 218 TABLE 214 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2022–JANUARY 2026 221 TABLE 215 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEGREE OF COMPETITION, 2025 225 TABLE 216 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION FOOTPRINT 231 TABLE 217 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: EQUIPMENT TYPE FOOTPRINT 232 TABLE 218 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: END-PRODUCT TYPE FOOTPRINT 233 TABLE 219 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TECHNOLOGY FOOTPRINT 234 TABLE 220 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 236 TABLE 221 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 237 TABLE 222 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2022−JANUARY 2026 240 TABLE 223 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2022−JANUARY 2026 243 TABLE 224 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: EXPANSIONS, JANUARY 2022−JANUARY 2026 249 TABLE 225 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW 251 TABLE 226 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252 TABLE 227 GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES 253 TABLE 228 GEA GROUP AKTIENGESELLSCHAFT: DEALS 254 TABLE 229 KÖRBER AG: COMPANY OVERVIEW 255 TABLE 230 KÖRBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 255 TABLE 231 KÖRBER AG: DEALS 256 TABLE 232 KÖRBER AG: EXPANSIONS 258 TABLE 233 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW 260 TABLE 234 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS/ SOLUTIONS/SERVICES OFFERED 261 TABLE 235 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCT LAUNCHES 261 TABLE 236 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: DEALS 261 TABLE 237 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW 264 TABLE 238 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 264 TABLE 239 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES 265 TABLE 240 SYNTEGON TECHNOLOGY GMBH: DEALS 266 TABLE 241 SYNTEGON TECHNOLOGY GMBH: EXPANSIONS 267 TABLE 242 ACG: COMPANY OVERVIEW 268 TABLE 243 ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 268 TABLE 244 ACG: DEALS 269 TABLE 245 ACG: EXPANSIONS 269 TABLE 246 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 271 TABLE 247 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 272 TABLE 248 THERMO FISHER SCIENTIFIC INC.: DEALS 273 TABLE 249 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS 274 TABLE 250 ROMACO GROUP: COMPANY OVERVIEW 275 TABLE 251 ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275 TABLE 252 ROMACO GROUP: PRODUCT LAUNCHES 276 TABLE 253 ROMACO GROUP: DEALS 277 TABLE 254 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW 278 TABLE 255 MARCHESINI GROUP S.P.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 278 TABLE 256 MARCHESINI GROUP S.P.A.: PRODUCT LAUNCHES 279 TABLE 257 MARCHESINI GROUP S.P.A.: DEALS 279 TABLE 258 MG2 S.R.L.: COMPANY OVERVIEW 281 TABLE 259 MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281 TABLE 260 MG2 S.R.L.: PRODUCT LAUNCHES 282 TABLE 261 GLATT GMBH: COMPANY OVERVIEW 283 TABLE 262 GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 283 TABLE 263 BAUSCH+STRÖBEL SE + CO. KG: COMPANY OVERVIEW 284 TABLE 264 COPERION GMBH: COMPANY OVERVIEW 285 TABLE 265 ELIZABETH COMPANIES: COMPANY OVERVIEW 286 TABLE 266 FETTE COMPACTING: COMPANY OVERVIEW 287 TABLE 267 FREUND: COMPANY OVERVIEW 288 TABLE 268 KORSCH AG: COMPANY OVERVIEW 289 TABLE 269 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH: COMPANY OVERVIEW 290 TABLE 270 LFA MACHINES: COMPANY OVERVIEW 291 TABLE 271 CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW 292 TABLE 272 OHARA TECHNOLOGIES: COMPANY OVERVIEW 293 TABLE 273 PRISM PHARMA MACHINERY: COMPANY OVERVIEW 294 TABLE 274 SAINTYCO: COMPANY OVERVIEW 295 TABLE 275 SILVERSON: COMPANY OVERVIEW 296 TABLE 276 YENCHEN MACHINERY CO., LTD.: COMPANY OVERVIEW 297 TABLE 277 QUALICAPS: COMPANY OVERVIEW 298 TABLE 278 COESIA S.P.A.: COMPANY OVERVIEW 299 TABLE 279 UHLMANN: COMPANY OVERVIEW 300 TABLE 280 AST, LLC: COMPANY OVERVIEW 301 TABLE 281 MAJOR SECONDARY SOURCES 304 TABLE 282 PRIMARY INTERVIEW PARTICIPANTS 305 TABLE 283 DATA CAPTURED FROM PRIMARY SOURCES 306 TABLE 284 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RISK ANALYSIS 313 FIGURE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION AND REGIONAL SCOPE 31 FIGURE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DURATION COVERED 32 FIGURE 3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SCENARIO 35 FIGURE 4 GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2021–2032 36 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, JANUARY 2022–JANUARY 2026 36 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 37 FIGURE 7 HIGH-GROWTH SEGMENTS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, 2026–2032 38 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD 39 FIGURE 9 HIGH EMPHASIS ON AUTOMATING PRODUCTION AND IMPROVING THROUGHPUT TO DRIVE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 40 FIGURE 10 PACKAGING MACHINES SEGMENT TO CAPTURE LARGEST MARKET SHARE IN 2026 AND 2032 41 FIGURE 11 LIQUID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2032 41 FIGURE 12 AUTOMATIC TECHNOLOGY TO DOMINATE MARKET SHARE FROM 2026 TO 2032 42 FIGURE 13 PACKAGING MACHINES SEGMENT AND US TO HOLD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA IN 2032 42 FIGURE 14 INDIA TO BE FASTEST-GROWING MARKET FOR PHARMACEUTICAL MANUFACTURING EQUIPMENT DURING FORECAST PERIOD 43 FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44 FIGURE 16 IMPACT ANALYSIS: DRIVERS 47 FIGURE 17 IMPACT ANALYSIS: RESTRAINTS 49 FIGURE 18 IMPACT ANALYSIS: OPPORTUNITIES 51 FIGURE 19 IMPACT ANALYSIS: CHALLENGES 53 FIGURE 20 PORTER’S FIVE FORCES ANALYSIS 58 FIGURE 21 PHARMACEUTICAL MANUFACTURING EQUIPMENT VALUE CHAIN ANALYSIS 64 FIGURE 22 PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM 66 FIGURE 23 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2022–2025 69 FIGURE 24 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, BY REGION, 2022–2025 70 FIGURE 25 INVESTMENT AND FUNDING SCENARIO, 2020–2024 71 FIGURE 26 IMPORT SCENARIO FOR HS CODE 8479-COMPLIANT PRODUCTS IN TOP FIVE COUNTRIES, 2021–2025 72 FIGURE 27 EXPORT SCENARIO FOR HS CODE 8479-COMPLIANT PRODUCTS IN TOP FIVE COUNTRIES, 2021–2025 73 FIGURE 28 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 74 FIGURE 29 PATENT APPLIED AND GRANTED, 2016–2025 93 FIGURE 30 DECISION-MAKING FACTORS CONSIDERED WHILE BUYING PHARMACEUTICAL MANUFACTURING EQUIPMENT 105 FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-PRODUCT TYPE 106 FIGURE 32 KEY BUYING CRITERIA, BY END-PRODUCT TYPE 107 FIGURE 33 PHARMACEUTICAL MANUFACTURING EQUIPMENT ADOPTION BARRIERS AND INTERNAL CHALLENGES 108 FIGURE 34 PHARMACEUTICAL MANUFACTURING EQUIPMENT END USERS 111 FIGURE 35 MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES 113 FIGURE 36 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 117 FIGURE 37 PACKAGING MACHINES SEGMENT TO DOMINATE MARKET FROM 2026 TO 2032 117 FIGURE 38 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE 169 FIGURE 39 SOLID SEGMENT TO ACCOUNT FOR LARGER SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2026 169 FIGURE 40 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY 173 FIGURE 41 AUTOMATIC SEGMENT TO CAPTURE LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2026 173 FIGURE 42 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR BETWEEN 2026 AND 2032 177 FIGURE 43 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT 179 FIGURE 44 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT 188 FIGURE 45 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT 199 FIGURE 46 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REVENUE ANALYSIS OF TOP PLAYER, 2020–2024 224 FIGURE 47 MARKET SHARE ANALYSIS OF COMPANIES OFFERING PHARMACEUTICAL MANUFACTURING EQUIPMENT, 2025 225 FIGURE 48 COMPANY VALUATION 227 FIGURE 49 FINANCIAL METRICS (EV/EBITDA) 227 FIGURE 50 BRAND COMPARISON 228 FIGURE 51 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY COMPANIES), 2025 229 FIGURE 52 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY FOOTPRINT 230 FIGURE 53 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 235 FIGURE 54 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT 252 FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 272 FIGURE 56 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN 302 FIGURE 57 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH APPROACH 303 FIGURE 58 DATA CAPTURED FROM SECONDARY SOURCES 304 FIGURE 59 CORE FINDINGS FROM INDUSTRY EXPERTS 306 FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEW, BY COMPANY TYPE, DESIGNATION, AND REGION 307 FIGURE 61 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: BOTTOM-UP APPROACH 308 FIGURE 62 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TOP-DOWN APPROACH 308 FIGURE 63 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE ESTIMATION (SUPPLY SIDE) 309 FIGURE 64 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: FACTOR ANALYSIS 310 FIGURE 65 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DATA TRIANGULATION 311 FIGURE 66 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH ASSUMPTIONS 312 FIGURE 67 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INSIGHTS FROM INDUSTRY EXPERTS 314

同分類最新報告（電子與半導體）

查看電子與半導體全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們